# Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

> **NCT07745569** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of New Mexico** · enrollment: 150 (estimated)

## Conditions studied

- PTSD
- PTSD - Post Traumatic Stress Disorder
- Major Depression
- Suicidality

## Interventions

- **DEVICE:** Transcranial Magnetic Stimulation
- **DRUG:** Psilocybin (drug)
- **BEHAVIORAL:** Neurofeedback

## Key facts

- **NCT ID:** NCT07745569
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745569, "Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*